Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Haizhen Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7564-794X; OpenAlex author ID A5057981820. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway. Co-author DOI 10.1016/j.canlet.2021.12.025↗
  2. Long-term survival of a patient with pancreatic cancer and lung metastasis: A case report and review of literature. Co-author DOI 10.12998/wjcc.v9.i30.9134↗
  3. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.1064↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaohang Zhao · 2 shared papers, 2017–2022 · strength 0.26
  2. Wenwei Yang · 1 shared paper, 2021 · strength 0.19
  3. Yongkun Sun · 1 shared paper, 2021 · strength 0.19
  4. Xiu Rong Dong · 1 shared paper, 2022 · strength 0.17
  5. Peng Nan · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.